Evidence
This page contains a snapshot of featured content which highlights evidence addressing key clinical questions including areas of uncertainty. Please see the main topic reference list for details of all sources underpinning this topic.
Cochrane Clinical Answers
Cochrane Clinical Answers (CCAs) provide a readable, digestible, clinically focused entry point to rigorous research from Cochrane systematic reviews. They are designed to be actionable and to inform decision making at the point of care and have been added to relevant sections of the main Best Practice text.
- What are the effects of vitamin A supplementation on mortality and morbidity among neonates in developing countries?
- In infants up to six months of age, how does vitamin A supplementation affect morbidity and mortality?
- What are the benefits and harms of early versus late cord clamping in pregnant women giving birth at term to a singleton infant?
- What are the effects of enteral iron supplementation when administered to preterm or low birth infants?
- How does zinc affect outcomes in children with suspected or confirmed HIV infection?
- How do multiple-micronutrient supplements affect outcomes in children with suspected or confirmed HIV infection?
- How does vitamin A affect outcomes in children with suspected or confirmed HIV infection?
- How does micronutrient supplementation affect outcomes in children with suspected or confirmed HIV infection?
- Is there randomized controlled trial evidence to support the use of furosemide in infants with transient tachypnea of the newborn?
- In infants one month to one year of age, is there randomized controlled trial evidence to support the use of sweet tasting solutions for reduction of needle-related procedural pain?
- How do topical emollients compare with routine skin care for preventing infection in preterm infants?
Use of this content is subject to our disclaimer